We are live on ! Find out more
PRQR icon

ProQR Therapeutics
PRQR

47 hedge funds and large institutions have $15.9M invested in ProQR Therapeutics in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 16 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,000% more call options, than puts

Call options by funds: $41K | Put options by funds: $1K

1.25% less ownership

Funds ownership: 31.05% → 29.8% (-1.2%)

8% less capital invested

Capital invested by funds: $17.2M → $15.9M (-$1.35M)

8% less funds holding

Funds holding: 51 → 47 (-4)

33% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 12

50% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 16

Holders
47
Holders Change
-4
Holders Change %
-7.84%
% of All Funds
0.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
8
Reduced
16
Closed
12
Calls
$41K
Puts
$1K
Net Calls
+$40K
Net Calls Change
-$47K

Top Buyers

Rank Fund Capital Flow
1
DCM
DAFNA Capital Management
California
+$522K
2
OM
Opaleye Management
Massachusetts
+$301K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$150K
4
Two Sigma Advisers
Two Sigma Advisers
New York
+$94.3K
5
Morgan Stanley
Morgan Stanley
New York
+$63.4K

Top Sellers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
-$771K
2
Renaissance Technologies
Renaissance Technologies
New York
-$272K
3
Citadel Advisors
Citadel Advisors
Florida
-$168K
4
Fidelity International
Fidelity International
Bermuda
-$128K
5
Jane Street
Jane Street
New York
-$104K
Name Holding Trade Value Shares
Change 		Change in
Stake
AI
26
Atom Investors
Texas
$21K -$1.29K -1,601 -5%
Osaic Holdings
27
Osaic Holdings
Arizona
$17K +$602 +750 +3%
Balyasny Asset Management
28
Balyasny Asset Management
Illinois
$16K +$17.2K +21,433 New
Jane Street
29
Jane Street
New York
$13K -$104K -129,533 -88%
TRCT
30
Tower Research Capital (TRC)
New York
$10K -$3.92K -4,883 -27%
BCM
31
Bayesian Capital Management
New York
$10K +$161 +200 +2%
AG
32
Algert Global
California
$8K – – –
Wells Fargo
33
Wells Fargo
California
$8K – – –
KAS
34
Kestra Advisory Services
Texas
$7K – – –
CAG
35
Csenge Advisory Group
Florida
$7K +$8.03K +10,000 New
JP Morgan Chase
36
JP Morgan Chase
New York
$4K -$771K -959,883 -99%
CG
37
Cutler Group
California
$4K -$1.1K -1,376 -19%
UBS Group
38
UBS Group
Switzerland
$4K +$4.09K +5,098 New
Zurich Cantonal Bank
39
Zurich Cantonal Bank
Switzerland
$3K – – –
AIM
40
Axiom Investment Management
New York
$3K +$3.61K +4,500 New
Citigroup
41
Citigroup
New York
$1K -$222 -276 -22%
BHWM
42
Beaird Harris Wealth Management
Texas
$1K – – –
CUAMC
43
China Universal Asset Management Company
China
$1K +$563 +701 New
Simplex Trading
44
Simplex Trading
Illinois
$1K +$1.93K +2,400 +5,581%
BNP Paribas Financial Markets
45
BNP Paribas Financial Markets
France
$34 -$2.38K -2,968 -98%
Citadel Advisors
46
Citadel Advisors
Florida
– -$168K -209,215 Closed
D.E. Shaw & Co
47
D.E. Shaw & Co
New York
– -$86K -110,552 Closed
Millennium Management
48
Millennium Management
New York
– -$51K -66,157 Closed
VF
49
Virtu Financial
New York
– -$48K -61,425 Closed
State Street
50
State Street
Massachusetts
– -$41K -52,123 Closed
1
2
3

PRQR Hedge Fund Activity: Q3 2022 in Review

47 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in ProQR Therapeutics (PRQR) for Q3 2022, worth a combined $15.9M — down 7.8% from $17.2M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of PRQR and 8 opened new positions — a net loss of 4 holders — while 16 trimmed existing stakes and 8 added.

The largest buyer was DAFNA Capital Management, opening a new position worth an estimated $522K. The largest seller was JP Morgan Chase, cutting an estimated $771K.

  • 47 institutional investors held ProQR Therapeutics (PRQR) as of Q3 2022, down from 51 in Q2 2022.
  • Funds reported $15.9M of ProQR Therapeutics stock for Q3 2022, down 7.8% quarter-over-quarter.
  • 8 funds opened new ProQR Therapeutics positions in Q3 2022 and 12 closed out, a net change of -4 holders.
  • The largest ProQR Therapeutics buyer in Q3 2022 was DAFNA Capital Management, an estimated $522K added.
  • The largest ProQR Therapeutics seller in Q3 2022 was JP Morgan Chase, an estimated $771K sold.

Based on aggregated 13F filings for Q3 2022.